mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice

Related articles

1. Immunogenicity of JN.1- and KP.2-Encoding mRNA COVID-19 Vaccines Against JN.1 Subvariants in Adult Participants

   This article has 13 authors:

   1. Amparo L. Figueroa
   2. Bethany Girard
   3. Darin K Edwards
   4. Arshan Nasir
   5. Kimball Johnson
   6. Steven Hack
   7. Xin Cao
   8. Elizabeth de Windt
   9. Veronica Urdaneta
   10. Frances Priddy
   11. Rituparna Das
   12. David C Montefiori
   13. Spyros Chalkias

2. A nasal vaccine candidate, based on S2 and N proteins from SARS-CoV-2, generates a broad antibody response systemic and at lower respiratory tract

   This article has 11 authors:

   1. Yadira Lobaina
   2. Rong Chen
   3. Dania Vazquez-Blomquist
   4. Edith Suzarte
   5. Miaohong Zhang
   6. Zhiqiang Zhou
   7. Yaqin Lan
   8. G Guillen
   9. Wen Li
   10. Yasser Perera
   11. Lisset Hermida

3. Antibody responses following COVID-19 vaccination and breakthrough infections in naïve and convalescent individuals suggests imprinting to the ancestral strain of SARS-CoV-2

   This article has 16 authors:

   1. Siddhartha Mahanty
   2. Emily M. Eriksson
   3. Peta Edler
   4. Francesca Mordant
   5. Nicholas Kiernan-Walker
   6. David J Price
   7. Sabine Braat
   8. Eamon Conway
   9. Vanessa Bryant
   10. Honghua Ding
   11. Leo Yi Yang Lee
   12. Louise Randall
   13. Ramin Mazhari
   14. COVID PROFILE consortium
   15. Ivo Mueller
   16. Kanta Subbarao